A three‐range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease-Reference-Cited by-同舟云学术

A three‐range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease

Published:2022-01 Issue:1 Volume:8 Page:
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:A&D Transl Res & Clin Interv

Author:

Brum Wagner S.¹²,de Bastiani Marco Antônio¹,Bieger Andrei¹,Therriault Joseph³⁴,Ferrari‐Souza João P.¹⁵,Benedet Andréa L.²³⁴,Saha‐Chaudhuri Paramita⁶,Souza Diogo O.¹⁷,Ashton Nicholas J.²⁸⁹,Zetterberg Henrik²¹⁰¹¹¹²,Pascoal Tharick A.⁵,Karikari Thomas²⁵,Blennow Kaj²¹⁰,Rosa‐Neto Pedro³⁴,Zimmer Eduardo R.¹¹³¹⁴,

Affiliation:

1. Graduate Program in Biological Sciences: Biochemistry Universidade Federal do Rio Grande do Sul (UFRGS) Porto Alegre Brazil

2. Department of Psychiatry and Neurochemistry The Sahlgrenska Academy at the University of Gothenburg Mölndal Sweden

3. Translational Neuroimaging Laboratory The McGill University Research Centre for Studies in Aging LaSalle Boulevard Verdun Canada

4. Department of Neurology and Neurosurgery McGill University Montreal Canada

5. Department of Neurology and Psychiatry University of Pittsburgh Pittsburgh USA

6. Department of Mathematics and Statistics University of Vermont Burlington USA

7. Department of Biochemistry UFRGS Porto Alegre Brazil

8. Department of Old Age Psychiatry Institute of Psychiatry Psychology & Neuroscience King's College London London UK

9. Wallenberg Centre for Molecular and Translational Medicine University of Gothenburg Gothenburg Sweden

10. Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Gothenburg Sweden

11. Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK

12. UK Dementia Research Institute at UCL London UK

13. Department of Pharmacology UFRGS Porto Alegre Brazil

14. Graduate Program in Biological Sciences: Pharmacology and Therapeutics UFRGS Porto Alegre Brazil

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Conselho Nacional de Desenvolvimento Científico e Tecnológico

European Research Council

BrightFocus Foundation

Instituto Serrapilheira

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/trc2.12270

Reference41 articles.

1. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

2. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

3. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

4. Targeted Recruitment Using Cerebrospinal Fluid Biomarkers: Implications for Alzheimer's Disease Therapeutic Trials

5. Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials?

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical Research;Neurology;2024-09-10

2. Biomarkers in Alzheimer’s disease;Clinica Chimica Acta;2024-08

3. Associations of endogenous estrogens, plasma Alzheimer’s disease biomarkers, and APOE4 carrier status on regional brain volumes in postmenopausal women;Frontiers in Aging Neuroscience;2024-07-09

4. The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022;Alzheimer's & Dementia;2023-09-12

5. Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape;Neuron;2023-09